Report Top Up a Page Previous Next Up a Map TOC Page Index File Index What's New Page Bottom
Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Infections and Infestations : Posters : Fluoroquinolone : Minimum Efficacy and Mutation Prevention Exposure Target Attainment Rates Against Streptococcus pneumoniae for Levofloxacin 500 mg and 750 mg and Moxifloxacin 400 mg published Wed, Nov 7, 2007 - 10:31 EST

Minimum Efficacy and Mutation Prevention Exposure Target Attainment Rates Against Streptococcus pneumoniae for Levofloxacin 500 mg and 750 mg and Moxifloxacin 400 mg

Presented at the 2002 IDSA Annual Meeting, Chicago, IL

Reprint currently not available.

Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Infections and Infestations : Posters : Fluoroquinolone : Minimum Efficacy and Mutation Prevention Exposure Target Attainment Rates Against Streptococcus pneumoniae for Levofloxacin 500 mg and 750 mg and Moxifloxacin 400 mg published Wed, Nov 7, 2007 - 10:31 EST
Report Top Up a Page Previous Next Up a Map TOC Page Index File Index What's New Page Top